Regeneron Pharmaceuticals, Inc. 価格 — チャート — 過去データ
828.50
-5.54 (-0.66%)
REGN
| %変化 | 週次 | 月次 | YTD | YoY | |
|---|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | -0.66% | 2.25% | 26.29% | 6.72% | 44.75% |
最新 Regeneron Pharmaceuticals, Inc. ニュース
REGN SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026 ↗
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Regeneron To Contact Him Directly…
Newsfile Corp · Aug 24, 17:35 UTC
United Airlines adds 2027 flights spanning Sardinia to Okinawa. Here's what it says about travel today ↗
United is betting big on premium, international travel with a host of new routes.
CNBC · Aug 25, 13:09 UTC
To cram more AI skills onto LinkedIn profiles, more job seekers are turning to 'time travel,' say researchers ↗
Workers are "time traveling" on LinkedIn to add AI skills to roles they left years ago, likely to get a leg up in a tough job market, researchers say.
CNBC · Aug 25, 13:00 UTC
Jim Cramer's top 10 things to watch in the stock market Tuesday ↗
Chip stocks are bouncing back, one day before Nvidia's earnings report Wednesday night.
CNBC · Aug 25, 12:59 UTC
Investors poured into Canadian ETFs right before trade talks broke down ↗
Investors misread the mood music on U.S.-Canadian talks, in a big way.
MarketWatch · Aug 25, 12:56 UTC
Stick with value stocks until everyone starts talking about them — they’re still under the radar, this Wall Street firm says ↗
BofA says investors continue to overlook value stocks, which work particularly well in a new era of higher interest rates and inflation.
MarketWatch · Aug 25, 12:40 UTC
関連
| 関連 | 価格 | %変化 |
|---|---|---|
| AbbVie Inc. | 264.52 | -0.17% |
| Abbott Laboratories | 116.67 | 0.03% |
| Amgen Inc. | 443.84 | 1.03% |
| Cigna Corporation | 280.45 | 1.06% |
| Danaher Corporation | 215.20 | -1.67% |
| Elevance Health Inc. | 402.63 | 0.52% |
| Eli Lilly and Company | 1,247.9 | -0.60% |
| Gilead Sciences, Inc. | 146.74 | 0.42% |